FDA panel rejects MDMA-assisted therapy for PTSD, citing lack of trust in Phase 3 clinical trial data.
Updated on: June 06,2024
0
FDA panel rejects MDMA-assisted therapy for PTSD, citing lack of trust in Phase 3 clinical trial data.
Updated on:June 06,2024
0